Volume 29, Issue 5 pp. 320-324
Therapeutic Hotline

Photodynamic therapy in lupus miliaris disseminatus faciei's scars

Francesco Borgia

Corresponding Author

Francesco Borgia

Dermatology Unit, Department of Clinical and Experimental Medicine

Address correspondence and reprint requests to: Francesco Borgia, MD, PhD, Dermatology Unit, Department of Clinical and Experimental Medicine, University Hospital “G. Martino,” Via Consolare Valeria, 98125 Messina, Italy, or email: [email protected].Search for more papers by this author
Roberta Giuffrida

Roberta Giuffrida

Dermatology Unit, Department of Clinical and Experimental Medicine

Search for more papers by this author
Mario Vaccaro

Mario Vaccaro

Dermatology Unit, Department of Clinical and Experimental Medicine

Search for more papers by this author
Maria Lentini

Maria Lentini

Department of Human Pathology, University Hospital “G. Martino”, Messina, Italy

Search for more papers by this author
Serafinella P. Cannavò

Serafinella P. Cannavò

Dermatology Unit, Department of Clinical and Experimental Medicine

Search for more papers by this author
First published: 30 June 2016
Citations: 12

Disclosure Statement: No funding source supported the work.

Abstract

Lupus miliaris disseminatus faciei is an uncommon granulomatous inflammatory disease, characterized by multiple, monomorphic, reddish translucent papules and nodules, mainly located on the face. Several therapeutic options have been employed with variable results, leaving residual disfiguring scars. On this topic, we report a case of significant improvement of red-atrophic scars in a 54-year-old male after three sessions of photodynamic therapy with 10% aminolevulinic acid. Owing to the high safety profile and the excellent cosmetic result, photodynamic therapy may be considered a useful tool to both prevent and treat undesirable scarring.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.